DEALTALK-Private equity takes on Big Pharma's carve-out challenge
July 11, 2014 at 15:26 PM EDT
July 11 (Reuters) - Big Pharma companies are trying to offload low-growth, mature drug portfolios to firms such as Blackstone Group LP and TPG Capital LP which need to figure out how to carve them out, in one of private equity's greatest dealmaking challenges.